Leukemia, Lymphoma and Myeloma Care
At Scott & White, patients diagnosed with leukemia, lymphoma, or myeloma benefit from a multidisciplinary team of cancer specialists providing personalized care. Comprehensive care is enhanced by the availability of innovative technologies and clinical trials.
The complexity of these cancers requires a comprehensive approach to treatment and involves many key cancer staff such as medical oncologists, hematologists, pathologists, radiologists, radiation oncologists, nuclear radiology physicians, social workers, cancer researchers, nurses and financial counselors.
Scott & White has autologous stem cell transplant therapy (using a patient's own blood stem cells) available for treatment of multiple myeloma and certain lymphomas. Allogeneic transplantation (using a donor's blood stem cells) is referred by the team to accredited partners within the state.
The patient is also considered an important member of the team when it comes to his or her own care. Together, the patient and the team determine the best treatment plan for the patient.
How to Make Referrals
Referrals from Scott & White physicians and self-referrals can contact the team coordinator in the Vasicek Cancer Treatment Center at 254-724-5918. Once the referred patient is registered into the Scott & White system, the team coordinator is notified for scheduling the patient for review by the Leukemia, Lymphoma and Myeloma Team. Referrals from outside physicians can contact the physician referral line at 254-724-2218.
The team coordinator will work with both the patient and the referring physician to obtain the medical documents needed for complete review by the team. Additional consults will be scheduled if needed. The Leukemia, Lymphoma and Myeloma Team strives to involve the referring physician and primary care physician as integral members of the team.
How the Leukemia, Lymphoma and Myeloma Team Works
The Leukemia, Lymphoma and Myeloma Team collaborates with the patient to ensure that each patient receives individualized care. The patient may meet with the team members involved in his or her care, including the medical oncologist, hematologist, clinical oncology social worker and financial counselor. Cancer researchers may also be involved if clinical trial participation is an option.
The patient meets with an experienced financial counselor, which allows the patient to ask questions regarding insurance and billing. This initial meeting can help put the patient’s mind at ease as important decisions are made about treatment. The patient may visit with a clinical oncology social worker who talks about a range of issues including psychological, social and practical needs. The clinical oncology social worker assesses and provides for the diverse and often complex needs of the individual patient, the family and supporters. Information on support, education, advocacy and problem solving is provided to the patient. A Scott & White chaplain is also available for consult if requested by the patient.
The patient is encouraged to visit the Glenda Tanner Vasicek Cancer Treatment Center to explore the resources available to them. The center partners with our cancer patients to help address the issues that may occur following a cancer diagnosis by providing resources to the patient. Educational pamphlets, books, videos and tapes are available at the center, while designated computer stations allow patients to access the Internet to search cancer information. A caring staff is available to answer questions and locate information for patients. Our educators also provide information on healthy lifestyles, as well as general chemotherapy teaching.
Innovative Research at Scott & White
Innovative clinical trials are available at Scott & White for leukemia, lymphoma and myeloma. Trials approved by the National Cancer Institute through cooperative groups are available, as well as industry-sponsored trials. The trials investigate new drugs, novel drug combinations and new technologies. Patients interested can be screened for eligibility by the cancer researchers at Scott & White.
View Scott & White's clinical trials for the treatment of leukemia, lymphoma and myeloma
